138 related articles for article (PubMed ID: 8517661)
1. Osteoblastic metastasis in advanced prostate cancer.
Koutsilieris M
Anticancer Res; 1993; 13(2):443-9. PubMed ID: 8517661
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer.
Koutsilieris M; Sourla A; Pelletier G; Doillon CJ
J Bone Miner Res; 1994 Nov; 9(11):1823-32. PubMed ID: 7863832
[TBL] [Abstract][Full Text] [Related]
3. Development of an animal model for prostate cancer cell metastasis to adult human bone.
Tsingotjidou AS; Zotalis G; Jackson KR; Sawyers C; Puzas JE; Hicks DG; Reiter R; Lieberman JR
Anticancer Res; 2001; 21(2A):971-8. PubMed ID: 11396190
[TBL] [Abstract][Full Text] [Related]
4. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
5. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
[TBL] [Abstract][Full Text] [Related]
7. In vivo models of human prostate cancer bone metastasis.
Brown JM
Methods Mol Med; 2003; 81():149-62. PubMed ID: 12725119
[No Abstract] [Full Text] [Related]
8. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
9. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
10. Human prostate cancer progression models and therapeutic intervention.
Chung LW; Kao C; Sikes RA; Zhau HE
Hinyokika Kiyo; 1997 Nov; 43(11):815-20. PubMed ID: 9436028
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of bone metastasis in prostate cancer: clinical implications.
Msaouel P; Pissimissis N; Halapas A; Koutsilieris M
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):341-55. PubMed ID: 18471791
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells.
Sourla A; Doillon C; Koutsilieris M
Anticancer Res; 1996; 16(5A):2773-80. PubMed ID: 8917385
[TBL] [Abstract][Full Text] [Related]
13. Role of Wnts in prostate cancer bone metastases.
Hall CL; Kang S; MacDougald OA; Keller ET
J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of osteoblastic bone metastasis of prostate cancer].
Yonou H; Ogawa Y; Ochiai A
Clin Calcium; 2006 Apr; 16(4):557- 64. PubMed ID: 16582505
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
16. Canine prostate stimulates osteoblast function using the endothelin receptors.
LeRoy BE; Sellers RS; Rosol TJ
Prostate; 2004 May; 59(2):148-56. PubMed ID: 15042615
[TBL] [Abstract][Full Text] [Related]
17. Prostatic osteoblastic factor.
Jacobs SC; Pikna D; Lawson RK
Invest Urol; 1979 Nov; 17(3):195-8. PubMed ID: 500315
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
[TBL] [Abstract][Full Text] [Related]
20. Current trials using bone-targeting agents in prostate cancer.
Tu SM; Lin SH
Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
